Education
About Us
Working with TipRanks
Follow Us
Atricure, Inc. (ATRC)
:ATRC
Earnings Data
Report Date
Feb 24, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.1Last Year’s EPS
-0.33Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflected a strong performance with significant revenue growth, improved profitability, and successful product launches across key segments. Despite some challenges in the minimally invasive ablation and hybrid therapy markets, the company is well-positioned with a solid cash position and raised guidance for the year.Company Guidance
Significant Revenue Growth
Total revenue for the quarter reached $134 million, marking a 16% increase year-over-year, driven by key franchises globally.
Improved Profitability and Cash Generation
Achieved nearly $18 million of adjusted EBITDA and over $30 million in cash generated in the third quarter.
Strong Product Launches
Successful launches of AtriClip FLEX-Mini, cryoSPHERE MAX, and EnCompass Clamp contributed to growth in appendage and pain management.
Appendage Management Growth
Worldwide revenue grew over 20% for appendage management, driven by AtriClip FLEX-Mini and PRO-Mini devices.
LeAAPS Clinical Trial Enrollment
Completed enrollment of over 6,500 patients in the LeAAPS trial, indicating strong interest and potential market expansion.
Open Ablation Growth
Open ablation growth accelerated to over 18%, with strong performance from EnCompass Clamp in the US and Europe.
Pain Management Expansion
Pain management franchise grew 28% in the quarter, driven by cryoSPHERE MAX and cryoSPHERE+ probes.
Cash Position and Guidance Increase
Ended the quarter with $147.9 million in cash and investments, raising full-year revenue guidance to $532-534 million.
ATRC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ATRC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 29, 2025 | $35.44 | $34.09 | -3.81% |
Jul 29, 2025 | $31.73 | $35.13 | +10.72% |
Apr 29, 2025 | $34.65 | $29.91 | -13.68% |
Feb 12, 2025 | $42.36 | $39.59 | -6.54% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Atricure, Inc. (ATRC) report earnings?
Atricure, Inc. (ATRC) is schdueled to report earning on Feb 24, 2026, After Close (Confirmed).
What is Atricure, Inc. (ATRC) earnings time?
Atricure, Inc. (ATRC) earnings time is at Feb 24, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ATRC EPS forecast?
ATRC EPS forecast for the fiscal quarter 2025 (Q4) is -0.1.